| 摘要 |
The use of a pentacyclic triterpene in the production of a pharmaceutical or neutraceutical composition to prevent or to treat a myocardial inflammatory disease, preferably acute or subacute myocarditis, to prevent or to treat a disease involving the appearance of calcium-salt deposits, and to prevent or to treat a disease involving fibrotic accumulation. Preferably, said pentacyclic triterpene is oleanolic acid. The invention further relates to a pharmaceutical or neutraceutical composition that comprises a triterpene in conjunction with at least one pharmaceutically acceptable adjuvant and/or vehicle or, when the composition is neutraceutical, a neutraceutically acceptable adjuvant and/or vehicle, for treating or preventing a myocardial inflammatory disease, preferably acute or subacute myocarditis, for preventing or treating a disease involving the appearance of calcium-salt deposits, and for preventing or treating a disease involving fibrotic accumulation. Preferably, said pentacyclic triterpene is oleanolic acid.
|
